TABLE 2.
Testing algorithm | Sensitivity (%) |
Specificity (%) |
|||
---|---|---|---|---|---|
Stage 1 (n = 114) | Stage 2 (n = 26) | Stage 3 (n = 29) | Healthy donorsb (n = 1,246) | Patients with a non-LD infection or condition (n = 54) | |
Traditionalc | 42.1 | 73.1 | 100 | 99.4 | 100 |
C6 ELISA alone | 56.1 | 100 | 100 | 98.4 | 98.1 |
2-ELISAd | 52.6 | 100 | 100 | 99.4 | 100 |
Adapted from reference 17.
Data from healthy donors from regions in which Lyme disease is endemic and from those in which it is not endemic were combined.
Traditional TTTA, WCS ELISA followed by Western blot analysis.
2-ELISA, WCS ELISA followed by C6-ELISA.